| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 03/26/2008 | CN101151345A Organic EL material, organic EL element employing the same, and process for producing organic EL element |
| 03/26/2008 | CN101151249A Cyclopentapyridine and tetrahydroquinoline derivatives |
| 03/26/2008 | CN101151248A 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroayryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity |
| 03/26/2008 | CN101148449A Salification method for 2-(6-quinolineamino)-6-cyclopropylamino-9H-purine |
| 03/26/2008 | CN101148448A Method for preparing N2-quinoline substituted purine derivative |
| 03/26/2008 | CN100376572C Anti-infective agents |
| 03/26/2008 | CN100376558C Process for the synthesis of 3-cyano-6-alkoxy-7-nitro-4-quinolones |
| 03/26/2008 | CN100376557C Quinoline derivatives as ligands for the neuropeptide y receptor |
| 03/25/2008 | US7348434 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them |
| 03/25/2008 | US7348433 3-[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-quinolin-2(1H)-ones or 5--[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-pyrrolo[3,2,1-IJ]quinolin-4(4H)-ones; type E antagonists; analgesics, antipyretics, antiinflammatory agents; side effect reduction |
| 03/25/2008 | US7348359 Retinoid X receptor modulators |
| 03/25/2008 | US7348353 Acetylene derivatives having mGluR 5 antagonistic activity |
| 03/25/2008 | US7348340 "caused" by the stimulation of nociceptive receptors and transmitted over intact neural pathways; 2-(4-Chlorophenyl)-quinoline-4,6-diamine; acute, persistent and neuropathic pain |
| 03/25/2008 | CA2268709C Hiv protease inhibitors |
| 03/20/2008 | WO2008033836A2 Process and intermediates for preparing integrase inhibitors |
| 03/20/2008 | WO2008033455A2 Biphenyl and heteroaryl phenyl derivatives as protein tyrosine phosphatases inhibitors |
| 03/20/2008 | WO2008032702A1 Fluoroboron compound having aromatic ring or salt thereof, and process for production of compound having cyclic ether-fused aromatic ring by using the same |
| 03/20/2008 | WO2008032099A2 Process for the preparation of montelukast, and intermediates therefor |
| 03/20/2008 | WO2008031824A1 Quinolinylmethyl compounds |
| 03/20/2008 | WO2008031509A1 ISOSERINE DERIVATIVES FOR USE AS COAGULATION FACTOR IXa INHIBITORS |
| 03/20/2008 | US20080070918 Heat Shock Protein-90 (HSP-90) inhibitors; cancer, inflammation, arthritis, angiogenesis, antimalaria, fungal and viral infections; 2-(4-Hydroxy-cyclohexylamino)-4-(3,7,7-trimethyl-5-oxo-5,6,7,8-tetrahydro-4H-cinnolin-1-yl)-benzamide for example; synthesis from corresponding benzonitriles |
| 03/20/2008 | US20080070880 Specific glucocorticosteroid compound having anti-inflammatory activity |
| 03/20/2008 | CA2663544A1 Isoserine derivatives for use as coagulation factor ixa inhibitors |
| 03/20/2008 | CA2662021A1 Quinolinylmethyl compounds |
| 03/20/2008 | CA2661943A1 Process and intermediates for preparing integrase inhibitors |
| 03/19/2008 | EP1899309A1 Heterocyclic compounds as agonists for the thyroid receptor |
| 03/19/2008 | EP1899299A2 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 03/19/2008 | EP1898914A1 Quinoline derivatives as antibacterial agents |
| 03/19/2008 | EP1898910A1 Quinoline derivatives as antibacterial agents |
| 03/19/2008 | EP1898909A1 Quinoline derivatives as antibacterial agents |
| 03/19/2008 | EP1646613B1 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors |
| 03/19/2008 | EP1363630B1 Kappa opioid receptor ligands |
| 03/19/2008 | EP1283711B1 Peptide deformylase inhibitors |
| 03/19/2008 | CN101146889A Luminous compound containing lanthanide ion |
| 03/19/2008 | CN101146808A Phenyl methanone derivatives and their use as glycine transporter 1 inhibitors |
| 03/19/2008 | CN101146786A Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 03/19/2008 | CN101146779A Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| 03/19/2008 | CN101146776A PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 03/19/2008 | CN101146773A 6, 7, 8, 9-tetrahydro-5-amino-5h-benzocyclohepten-6-ol derivatives and related compounds used as anti-inflammatory agents |
| 03/19/2008 | CN101143845A Substituted quinoline formyl guanidine derivative, its preparation method and medical use |
| 03/19/2008 | CN101143830A Organic electroluminescent material and application thereof |
| 03/19/2008 | CN100375742C 4-oxoquinoline compounds and its use |
| 03/18/2008 | US7345174 Selectively inducing terminal differentiation of neoplastic cells; antiproliferative agents; antineoplastic agents; antitumor agents; melanomes; acute leukemia, multiple myeloma; carcinomas; neuroblastoma; N-t-butoxycarbonyl- omega -methyl - alpha -aminosuberateanilide |
| 03/18/2008 | US7345095 Alpha, beta -peptide inhibitors; Alzheimer's disease; 2-(4-Chloro-benzenesulfonylamino)-3-phenyl-propionic acid methyl ester |
| 03/18/2008 | US7345068 Aromatic amino acid derivatives and medicinal compositions |
| 03/18/2008 | US7345064 5-(4-pyridyl)valeric acid N-[2-(1-adamantyl)ethyl]-N-pentylamide; Autoimmune diseases such as rheumatoid arthritis, allergy and diabetes |
| 03/18/2008 | US7345058 Pyrazoles |
| 03/13/2008 | WO2008029670A1 Organic electroluminescent device material and organic electroluminescent device |
| 03/13/2008 | WO2008029523A1 Quinolinium ion derivatives, process for the production of the derivatives, products made by using the same, and reduction and oxidation methods with the derivatives |
| 03/13/2008 | WO2008029282A2 Aqueous formulation comprising an antitumor agent |
| 03/13/2008 | WO2008029199A1 Positively charged water-soluble prodrugs of n-arylanthranilic acids with very fast skin penetration rate |
| 03/13/2008 | WO2008028691A1 N-(1-hetarylpiperidin-4-yl)(het)arylamides as ep2 receptor modulators |
| 03/13/2008 | WO2008028624A1 Fungicides |
| 03/13/2008 | WO2008028427A1 Derivatives of 2-phenyl-3-hydroxyquinoline-4(1h)-one and methods of their preparation and utilization |
| 03/13/2008 | WO2007139797A3 Method of preparing 4-halogenated quinoline intermediates |
| 03/13/2008 | WO2007107311A3 Organic sulphinic acid derivatives |
| 03/13/2008 | US20080064722 Agent for promoting interferon-y production |
| 03/13/2008 | US20080064720 Very Late Antigen-4 dependent inflammatory disease; asthma, allergic rhinitis, sinusitis, conjunctivitis, food allergy, inflammatory skin disorders, autoimmune disorders, or atherosclerosis, inflammatory skin disorder; methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-hydroxy-2-propenoate |
| 03/13/2008 | US20080064037 Rna-selective probes for live cell imaging of nuclear structure and function |
| 03/13/2008 | US20080063599 Compounds Which Can Be Used To Diagnose And Monitor Diseases Associated With The Formation Of Amyloid Protein Fibrils |
| 03/13/2008 | CA2662281A1 N-(1-hetarylpiperidin-4-yl)(het)arylamides as ep2 receptor modulators |
| 03/13/2008 | CA2662259A1 Fungicides |
| 03/13/2008 | CA2660685A1 Aqueous formulation comprising an antitumor agent |
| 03/12/2008 | EP1897881A2 Compounds useful for the treatment of obesity, type II diabetes and CNS disorders |
| 03/12/2008 | EP1897876A2 Compounds useful for the treatment of obesity, type II diabetes and CNS disorders |
| 03/12/2008 | EP1897542A1 Aqueous formulation comprising an antitumor agent |
| 03/12/2008 | EP1896461A2 Bis-aryl kinase inhibitors and their use in the treatment of inflammation, angiogenesis and cancer |
| 03/12/2008 | EP1896418A1 Quinoline 3 -sulfonate esters as nk3 receptor modulators |
| 03/12/2008 | EP1896396A1 Anthranilic acid derivatives |
| 03/12/2008 | EP1534275B1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 03/12/2008 | CN101142187A 离子型有机化合物 Ionic organic compounds |
| 03/12/2008 | CN101139319A Substituted quinoline trimer indene derivative and method for making same |
| 03/12/2008 | CN100374425C Aryl and heteroaryl urea CHK1 inhibitors for use as radiosensitizers and chamosensitizers |
| 03/12/2008 | CN100374423C Process for the preparation of 4-methyl-7-aminoquinolones |
| 03/12/2008 | CN100374422C Crystalline forms of pitavastatin calcium |
| 03/11/2008 | US7342026 combining substituted quinolines with a carrier; leishmania/HIV infection; viricide, parasiticide |
| 03/11/2008 | US7342020 Effective against MMP 9 and 13; arthritis, atherosclerosis; synthesis |
| 03/11/2008 | CA2310664C Substituted 2-aminoacetamides and the use thereof |
| 03/11/2008 | CA2223535C 2,4-pentadienoic acid derivatives having retinoid-like biological activity |
| 03/06/2008 | WO2008026748A1 Antitumor agent for undifferentiated gastric cancer |
| 03/06/2008 | WO2008025816A1 Polymorphic crystal form of a indan-2-ylamino-hydroxyethyl-quinolinone maleate derivative as beta-adrenoceptor agonist |
| 03/06/2008 | US20080058515 indazolylacrylamide derivatives are useful in the treatment of diseases associated with inappropriate SGK-1 activity |
| 03/06/2008 | US20080058372 2,5-bis{[alkyl(or aryl)imino]aminophenyl}furans and thiophenes; "reversed" amidines; DNA-binding affinities; microbiocide; mycobacterial, fungal, protozoal infection; Mycobacterium tuberculosis, Trypanosoma spp., Candida albicans, Aspergillus spp., Cryptosporidium parvum, Giardia lamblia, Plasmodium spp. |
| 03/06/2008 | US20080058335 Pain, inflammatory or immune disorders, neurological disorders, cancers of the immune system, respiratory disorders, cardiovascular disorders, neuroprotection; e.g. 5-chloro-N-[(2Z)-5-(1-hydroxy-1-methylethyl)-3-[((cis)-3-methoxycyclobutyl)methyl]-4-methyl-1,3-thiazol-2(3H)-ylidene]-2-methoxybenzamide |
| 03/06/2008 | US20080058293 Quinoline Derivates and Their Use in Therapy |
| 03/06/2008 | US20080056987 Inhibitor of Eph receptor kinase; treat angiogenesis, lymphangiogenesis or asculogenesis, disorder of the blood vessels, hyperproliferation of body cells, chronic or acute neurodegenerative disorder; enteral, parenteral and oral administration |
| 03/06/2008 | CA2659144A1 Polymorphic crystal form of a indan-2-ylamino-hydroxyethyl-quinolinone maleate derivative as beta-adrenoceptor agonist |
| 03/05/2008 | EP1894918A1 Amorphous salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide and process for producing the same |
| 03/05/2008 | EP1893580A1 NOVEL SALT FORM OF A ß2 -ADRENERGIC AGONIST QUINOLIN-2-ONE DERIVATIVE |
| 03/05/2008 | EP1893560A2 3-methanesulfonylquinolines as gaba-b enhancers |
| 03/05/2008 | EP1732541A4 Cyclic compounds |
| 03/05/2008 | EP1633748B1 Quinoline derivatives as phosphodiesterase inhibitors |
| 03/05/2008 | CN101137625A Cinnamate salts of a beta-2 adrenergic agonist |
| 03/05/2008 | CN101137376A Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use |
| 03/05/2008 | CN101134742A Method for synthesizing 2,2'-biquinoline |
| 03/04/2008 | US7339063 Quinolyl organic germanium ester and the synthesis method thereof |
| 03/04/2008 | US7339062 Method for producing a 3,5-dihydroxy-6-heptenoate |
| 03/04/2008 | US7339061 3-(4-oxo-4H-chromen-2-yl)-(1H)-quinolin-4-one derivatives, method for preparing same and pharmaceutical compositions containing same |
| 03/04/2008 | US7338956 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 02/28/2008 | WO2008024961A1 Dihydropyridazine, tetrahydropyridine, chromanone, and dihydronaphthalenone derivatives as heat-shock protein 90 inhibitors |